0001950047-23-006329.txt : 20231219 0001950047-23-006329.hdr.sgml : 20231219 20231219165331 ACCESSION NUMBER: 0001950047-23-006329 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231219 DATE AS OF CHANGE: 20231219 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 231498135 BUSINESS ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1000 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Mesa Nilda CENTRAL INDEX KEY: 0001756697 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORPORATION STREET 2: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 144 1 primary_doc.xml 144 0001756697 XXXXXXXX LIVE 0001082554 UNITED THERAPEUTICS CORPORATION 000-26301 1000 Spring Street SILVER SPRING MD 20910 (301) 608-9292 NILDA MESA Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

605 148165.47 46993601 12/19/2023 NASDAQ Common 07/08/2022 Restricted Stock Issuer N 605 07/08/2022 Not Applicable Y 12/19/2023 /s/ Nilda Mesa